BMJ  2007;334:272 (10 February), doi:10.1136/bmj.39112.454387.BE

Editorials

Reducing harm from radiotherapy

Healthcare systems should follow the lead developed in other high risk industries

The first 150 words of the full text of this article appear below.

Like most treatments, radiotherapy has the power to heal but also to harm.1 Worldwide, around 10 million people are newly diagnosed with cancer each year and 40-50% will receive radiotherapy.2 In the United Kingdom, around 200 linear accelerators deliver 100 000 courses of radiotherapy in 1.5 million fractions annually; this results in roughly 4.25 million doses of radiation for cancer treatment each year (data from the Health Protection Agency (www.hpa.org.uk/) and the National Cancer Services Analysis Team (www.canceruk.net/)).

Because of the hazardous nature of radiation, an extensive framework of protocols, standards, and legislation is in place to protect patients and healthcare workers.3 4 5 6 The World Health Organization World Alliance for Patient Safety has this year taken up the challenge of making radiotherapy safer (www.who.int/patientsafety/en). It will deal with two key questions. Firstly, can standardised safety interventions be developed that reliably and consistently reduce the risk . . . [Full text of this article]

Liam Donaldson, chief medical officer for England

1 Department of Health, London SW1A 2NS

liam.donaldson@dh.gsi.gov.uk


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

Relevant Articles

Service delivery should be funded centrally
Bruce Sizer, Philip Murray, and Alan Lamont
BMJ 2007 334: 381. [Extract] [Full Text] [PDF]

Culture of secrecy must be tackled
Michael V Williams
BMJ 2007 334: 381. [Extract] [Full Text] [PDF]

Young military veterans show similar help seeking behaviour
Lauren N van Staden, Nicola Fear, Amy Iversen, Claire French, Christopher Dandeker, and Simon Wessely
BMJ 2007 334: 382. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

  • WILLIAMS, M V, McKENZIE, A (2008). Can we afford not to implement in vivo dosimetry?. Br. J. Radiol. 81: 681-684 [Full text]  
  • JONES, B, DALE, R G (2008). Radiobiological compensation of treatment errors in radiotherapy. Br. J. Radiol. 81: 323-326 [Abstract] [Full text]  
  • Williams, M V (2007). Improving patient safety in radiotherapy by learning from near misses, incidents and errors. Br. J. Radiol. 80: 297-301 [Abstract] [Full text]  
  • Sizer, B., Murray, P., Lamont, A. (2007). Service delivery should be funded centrally. BMJ 334: 381-381 [Full text]  
  • Williams, M. V (2007). Culture of secrecy must be tackled. BMJ 334: 381-381 [Full text]  

Rapid Responses:

Read all Rapid Responses

Safety issues caused by lack of government leadership
Richard Evans
bmj.com, 14 Feb 2007 [Full text]
Human error is,indeed, inevitable
Jonathan J Nicoll, et al.
bmj.com, 14 Feb 2007 [Full text]
Radiotherapy Service Delivery is a national rather than local issue, and should be funded centrally
Bruce Sizer, et al.
bmj.com, 14 Feb 2007 [Full text]
Reducing Harm from Radiotherapy
Michael V Williams
bmj.com, 15 Feb 2007 [Full text]
Adequate in-vivo dosimetry would prevent most accidental exposures
Katharine Tylko, et al.
bmj.com, 20 Feb 2007 [Full text]
Advanced 3-dimensional dosimtery could be the answer?
Mark Godber, et al.
bmj.com, 21 Feb 2007 [Full text]



Access jobs at BMJ Careers
Whats new online at Student 

BMJ